Abu Dhabi develops new antibody to fight covid

Abu Dhabi | Abu Dhabi acquires new antibody treatment (Regenkov) to fight Kovid Immunosuppressive therapy combines the monoclonal antibody (synthetic antibody) of Kazirivimab and Indivimab to strengthen the immune system against Kovid.

Therapy is effective for those with mild to moderate Kovid symptoms. Abu Dhabi Health Ministry Undersecretary Dr. Mohd. Jamal al-Kabi said. This will be beneficial for the prevention and treatment of Kovid. The goal is to prevent the spread of the disease by providing the most advanced and safest drug against Kovid. At the same time, he said, this is not a vaccine against Kovid. The new therapy was developed by Swiss drugmaker Roche and the Abu Dhabi Health Department. The U.S. Food and Drug Administration approved Regen Cove in August for emergency use.

Alkabi said 97% of the thousands of patients who were given the Sotrovimab antiviral drug in the UAE were cured within 14 days.



Leave a Reply

Your email address will not be published. Required fields are marked *